Jinyu bio-technology: The industry is in the lowest valley period in history. New products next year will contribute to revenue growth | Directly addressing the earnings conference.
①At the performance briefing, jinyu bio-technology's chairman Zhang Chongyu frankly admitted that the industry is currently experiencing the lowest trough in history; ②The company stated that the competition in the pig vaccine sector is intense, and it will maintain its market share. Several new vaccines will be launched in the next two years. It is expected that the new products next year will contribute to a certain increase in revenue.
Shanghai Shen Lian Biomedical Corporation: Intensified competition weakens the leading profit of pig vaccines, will expand new product development | Directly hit earnings conference
①Affected by the downturn in the downstream livestock breeding market and price decline, the leading pig vaccine company shanghai shen lian biomedical corporation saw an increase in revenue but not in profit; ②Nie Dongsheng stated at the earnings conference that in the second half of 2024, shanghai shen lian biomedical corporation will timely adjust its short-term and medium-to-long-term operational goals, expand the market development and global strategy of new products, including the market share increase of foot-and-mouth disease inactivated vaccines for cattle and sheep, swine circovirus vaccines sales, and product entry into the supply chain systems of multiple large-scale breeding groups.
The animal protection industry is under pressure, with pulike biological engineering,inc. H1 net profit falling by more than thirty percent. The pet track may become a new growth point. | Interpretations
①In the first half of the year, the net income of the animal protection industry has generally declined, with Pulike Biological Engineering, Inc. declining by more than 30%, but the company's net income in the second quarter has narrowed compared to the first quarter. ②The company's pet track has experienced a breakthrough in the first half of the year and may become a new growth driver in the future. ③Looking ahead to the second half of the year, industry experts interviewed by reporters believe that when the downstream breeding industry's profits rebound, there will also be a certain upward trend in the profits of the upstream animal protection enterprises.
“Double random” spot checks were effective, and 8 company problems were revealed! Hailey Biotech and others announced the results of the Securities Regulatory Bureau's investigation
① Hailey Biotech announced tonight that the Shanghai Securities Regulatory Bureau has taken measures to issue a warning letter against the company and related responsible persons. ② According to an article published on the official website of the Shanghai Securities Regulatory Bureau in June last year, two random spot checks were carried out for on-site inspections of listed companies in Shanghai in 2023, and 8 random targets were selected; an article published in November last year showed that the inspection work was completed. ③ The reporter saw from the announcements of 8 listed companies that all had problems with credit disclosure.
Featured Announcements | Taobo: The total sales volume of the retail and wholesale business in the past fiscal quarter recorded a low 20-30% year-on-year increase
Shiyao Group: The first domestic anti-GFRAL monoclonal antibody JMT203 was approved for clinical trials in China; L'Occitane: Group sales reached 2,135 billion euros in FY2023.
Nikola, ChargePoint Partner to Drive Deployment of EV Charging Infrastructure